InsiderTrades

Form 4 for CORT CORCEPT THERAPEUTICS INC

Accepted 2026-08-18 16:30:06 ET · period of report 2026-08-17 · accession 0001193125-26-355560 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2026-08-18 16:30 2026-08-17 CORT Robb Gary Charles Chief Business Off G - Gift $0.00 -125 13.4K -0.9% $0
I 2026-08-18 16:30 2026-08-17 CORT Robb Gary Charles Chief Business Off S - Sale $116.26 -10.0K 39.7K -20% -$1.16M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-08-17 G D 125 $0.00 13,426 D — — (F1) Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
2 Common Common Stock 2026-08-17 S D 10,000 $116.26 39,716 I Gary Charles Robb TTE Robb Revocable Trust — — (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.00 to $116.54 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. (F3) These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee.